http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1095185-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 1965-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1967-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1095185-A |
| titleOfInvention | Phenylalanine derivatives |
| abstract | Novel compounds of Formula (I) <FORM:1095185/C2/1> in which M is a hydrogen atom, an alkali metal cation, a C1- 5 alkyl radical, or an aryl-substituted C1- 5 alkyl radical; n is 0, 1 or 2; R2 is a hydrogen atom or an acetyl or formyl radical; and each of R3 and R4 is a hydrogen atom, or a C1- 5 alkyl radical, or R3 and R4 together represent a methylene radical, and the mineral acid addition salts thereof, are prepared by reducing a nitrile of Formula (II) <FORM:1095185/C2/2> in which R1 is a C1- 5 alkyl or aryl-substituted C1- 5 alkyl radical, and R5 is an acetyl or formyl radical, in an inert solvent with hydrogen under pressure in the presence of a non-oxidizing mineral acid and a hydrogenation catalyst, to produce a mineral acid addition salt of an amino-acid of Formula (III) <FORM:1095185/C2/3> optionally followed (1) by treatment with a dilute solution of a mineral acid to produce the mineral acid addition salt of a compound in which both R1 and R5 are hydrogen, followed when R3 and/or R4 are alkyl, if desired, by reaction with a concentrated aqueous mineral acid at an elevated temperature to produce the mineral acid-addition salt of the corresponding compound in which R3 and R4 are hydrogen; (2) when R3 and/or R4 are alkyl, by treatment with a concentrated aqueous mineral acid at an elevated temperature to produce the mineral acid addition salt of the corresponding compound in which R1, R5, R3 and R4 are all hydrogen; or (3) by reaction with an alkali metal alkoxide in an aqueous alkanol solvent at an elevated temperature to produce the alkali metal salt of the corresponding compound in which R5 is hydrogen. The a -aminomethylphenylalanine acid addition salts obtained from (1) and (2) above may be converted to the free base by reaction with an alkylene oxide or inorganic base, or to an ester by reaction with an alcohol in the presence of a mineral acid at an elevated temperature. The 2 - acylamino - 2 - cyano - 3 - phenylpropionic acid ester starting materials may be obtained by reducing a benzaldehyde, converting the benzyl alcohol obtained to the halide, and treating the halide with sodium hydride and a cyanoacetate of formula R5NHCH(CN)COOR1. The a -acylaminocyanoacetic acid ester may be prepared by reacting a cyano-acetic acid ester with sodium nitrite in glacial acetic acid and treating the a -oximinocyanoacetic acid ester obtained with zinc dust in acetic acid.ALSO:Therapeutic compositions active as inhibitors of mammalian dicarboxylase and having anti-hypertensive activity, which may be administered orally or parenterally, contain as active ingredient a compound of formula:- <FORM:1095185/A5-A6/1> in which M is a hydrogen atom, an alkali metal cation, a C1-5 alkyl or aryl-substituted C1-5 alkyl group; n is 0, 1 or 2; R2 is a hydrogen atom, or an acetyl or formyl group; and each of R3 and R4 is a hydrogen atom or a C1-5 alkyl radical, or R3 and R4 together represent a methylene radical, or a mineral acid addition salt thereof, and, if desired, any other anti-hypertensive agent. |
| priorityDate | 1964-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.